Melissa D. Cooper

Rapid Learning Systems for Streamlined Care
05/21/2014
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and...
05/21/2014
First Report Managed Care
Conference Insider
Treating Patients with Relapsing MS
06/10/2015
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an...
06/10/2015
First Report Managed Care
News
Economic Burden of Unintended Pregnancy on Employer-Sponsored Health Insurance
07/30/2015
Approximately 28.8% of pregnancies are unintended under employer-sponsored insurance plans, and they account for 27.4% of annual delivery costs to employers.
Approximately 28.8% of pregnancies are unintended under employer-sponsored insurance plans, and they account for 27.4% of annual delivery costs to employers.
Approximately 28.8% of...
07/30/2015
First Report Managed Care
Roflumilast Associated with COPD Cost and Healthcare Utilization
05/21/2014
Tampa—Exacerbation is the leading cause of hospitalization and death in patients with chronic obstructive pulmonary disease (COPD). In 2010, COPD-related annual total cost was estimated at $49.9 billion. Approximately $29.5 billion of the...
Tampa—Exacerbation is the leading cause of hospitalization and death in patients with chronic obstructive pulmonary disease (COPD). In 2010, COPD-related annual total cost was estimated at $49.9 billion. Approximately $29.5 billion of the...
Tampa—Exacerbation is the...
05/21/2014
First Report Managed Care
Conference Insider
Obstacles in the Pursuit of Optimal Hyperkalemia Management
06/10/2015
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in...
06/10/2015
First Report Managed Care
Coordinating Managed Care and Long-Term Services and Support
06/18/2015
In the United States, two-thirds of nursing home residents’ costs are funded by Medicaid.
In the United States, two-thirds of nursing home residents’ costs are funded by Medicaid.
In the United States, two-thirds...
06/18/2015
First Report Managed Care
HIV Treatment Optimization
05/21/2014
Tampa—Medicaid is the largest payer of HIV care in the United States, covering about 4 in 10 patients with HIV. According to estimates, Medicaid spends $5.3 billion on HIV prevention and treatment, with prescription drugs as the largest...
Tampa—Medicaid is the largest payer of HIV care in the United States, covering about 4 in 10 patients with HIV. According to estimates, Medicaid spends $5.3 billion on HIV prevention and treatment, with prescription drugs as the largest...
Tampa—Medicaid is the largest...
05/21/2014
First Report Managed Care
Conference Insider
Idiopathic Pulmonary Fibrosis Treatment Option
06/10/2015
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease in which the tissue in the lungs hardens causing a progressive decline in lung function. IPF typically occurs in Caucasian males ≥50 years of age who have a history of...
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease in which the tissue in the lungs hardens causing a progressive decline in lung function. IPF typically occurs in Caucasian males ≥50 years of age who have a history of...
Idiopathic pulmonary fibrosis...
06/10/2015
First Report Managed Care
News
Effect of Medicare Part D and Generics on Breast Cancer Treatment
06/18/2015
In the United States, breast cancer is the second most common cancer diagnosis and the second most fatal form of cancer among women. Endocrine therapy agents, including aromatase inhibitors (AIs) and tamoxi- fen, have shown effectiveness in...
In the United States, breast cancer is the second most common cancer diagnosis and the second most fatal form of cancer among women. Endocrine therapy agents, including aromatase inhibitors (AIs) and tamoxi- fen, have shown effectiveness in...
In the United States, breast...
06/18/2015
First Report Managed Care
ACE and ARB Treatment among Medicare Beneficiaries with Diabetes and Hypertension
04/22/2014
Between 2000 and 2010, the percentage of patients aged ≥65 years with diabetes and hypertension increased from 9% to 15%. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) have proven to decrease the...
Between 2000 and 2010, the percentage of patients aged ≥65 years with diabetes and hypertension increased from 9% to 15%. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) have proven to decrease the...
Between 2000 and 2010, the...
04/22/2014
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use